Variable | Control | Intervention | P value | |
---|---|---|---|---|
Age (Years) | 58.25 ± 13.1 | 56.93 ± 12.3 | 0.47 | |
Male/Female | 22/16 | 24/18 | 0.39 | |
APACHE | 22.7 ± 4.26 | 24.5 ± 5.35 | 0.57 | |
SOFA | 10.7 ± 2.70 | 12.54 ± 2.65 | < 0.001 | |
Pneumonia | 0.56 | |||
VAP | 12 | 13 | ||
CAP | 10 | 11 | ||
HAP | 18 | 16 | ||
PSI | 188.52 ± 52 ± 33.87 | 194.72 ± 29.83 | 0.38 | |
CURB-65 | 3.55 ± 0.71 | 3.72 ± 0.67 | 0.26 | |
MV duration (day) | 8.92 ± 2.96 | 4.05 ± 2.29 | < 0.001 | |
ICU LOS (day) | 14.15 ± 3.12 | 12.77 ± 3.71 | 0.07 | |
Vasopressor use (day) | 3.39 ± 1,23 | 2.28 ± 1.24 | 0.003 | |
Vasopressor dose (microg/min) | 8.26 ± 3.58 | 6.8 ± 3.18 | 0.14 | |
Need to mechanical ventilationα | 9 | 5 | 0.24 | |
Mortality | 11 | 6 | 0.17 | |
Comorbiditiesa | AKI | 22(55%) | 16(40%) | P = 0.144 X2 = 6.763 |
DM | 11(27.5%) | 25(62.5%) | ||
Cardiovascular | 13(32.5%) | 18(45%) | ||
Cerebrovascular | 8(20%) | 11(27.5%) | ||
Malignancy | 5(12.5%) | 3(7.5%) |